We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitation... Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Show more
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First...
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through...
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality...
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality...
First quarter 2024 financial results to be reported on Tuesday, May 7, 2024 Investor Day to replace first quarter 2024 earnings conference call; quarterly calls to resume regular cadence with...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.27 | 4.57627118644 | 5.9 | 6.5999 | 5.35 | 2820201 | 6.04668985 | CS |
4 | 0.27 | 4.57627118644 | 5.9 | 6.5999 | 4.06 | 3553991 | 5.40105265 | CS |
12 | -3.29 | -34.778012685 | 9.46 | 11.31 | 4.06 | 2682362 | 7.50813831 | CS |
26 | 4.06 | 192.417061611 | 2.11 | 11.31 | 2.05 | 2135927 | 6.53763171 | CS |
52 | -0.1 | -1.59489633174 | 6.27 | 11.31 | 1.995 | 1564833 | 5.85911952 | CS |
156 | -8.468 | -57.8494329826 | 14.638 | 15.316 | 1.995 | 1106873 | 6.24407595 | CS |
260 | 2.64 | 74.7875354108 | 3.53 | 24.3 | 1.995 | 1035016 | 7.64014831 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions